341 related articles for article (PubMed ID: 10572233)
21. Aromatase inhibitors and inactivators in breast cancer.
Lønning PE
BMJ; 2001 Oct; 323(7318):880-1. PubMed ID: 11668120
[No Abstract] [Full Text] [Related]
22. Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?
Carlini P; Frassoldati A; De Marco S; Casali A; Ruggeri EM; Nardi M; Papaldo P; Fabi A; Paoloni F; Cognetti F
Ann Oncol; 2001 Nov; 12(11):1539-43. PubMed ID: 11822752
[TBL] [Abstract][Full Text] [Related]
23. The evolving role of aromatase inhibitors in breast cancer.
Mokbel K
Int J Clin Oncol; 2002 Oct; 7(5):279-83. PubMed ID: 12402060
[TBL] [Abstract][Full Text] [Related]
24. Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
Pérez N; Borja J
J Int Med Res; 1992 Aug; 20(4):303-12. PubMed ID: 1387368
[TBL] [Abstract][Full Text] [Related]
25. Aromatase inhibitors in the treatment of postmenopausal breast cancer.
Bajetta E; Zilembo N; Bichisao E
Drugs Aging; 1999 Oct; 15(4):271-83. PubMed ID: 10582774
[TBL] [Abstract][Full Text] [Related]
26. Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients.
Anker GB; Refsum H; Ueland PM; Johannessen DC; Lien EA; Lonning PE
Clin Chem; 1999 Feb; 45(2):252-6. PubMed ID: 9931048
[TBL] [Abstract][Full Text] [Related]
27. Pivotal trials of letrozole: a new aromatase inhibitor.
Smith IE
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):41-4. PubMed ID: 9556791
[TBL] [Abstract][Full Text] [Related]
28. An overview of the use of non-steroidal aromatase inhibitors in the treatment of breast cancer.
Buzdar A
Eur J Cancer; 2000 Sep; 36 Suppl 4():S82-4. PubMed ID: 11056331
[TBL] [Abstract][Full Text] [Related]
29. Aromatase inhibitors: past, present and future in breast cancer therapy.
Dutta U; Pant K
Med Oncol; 2008; 25(2):113-24. PubMed ID: 17973095
[TBL] [Abstract][Full Text] [Related]
30. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.
Buzdar AU; Robertson JF; Eiermann W; Nabholtz JM
Cancer; 2002 Nov; 95(9):2006-16. PubMed ID: 12404296
[TBL] [Abstract][Full Text] [Related]
31. Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrol.
Messori A; Cattel F; Trippoli S; Vaiani M
Anticancer Drugs; 2000 Oct; 11(9):701-6. PubMed ID: 11129731
[TBL] [Abstract][Full Text] [Related]
32. Anastrozole: a new selective nonsteroidal aromatase inhibitor.
Goss PE; Tye LM
Oncology (Williston Park); 1997 Nov; 11(11):1697-703; discussion 1707-8. PubMed ID: 9394367
[TBL] [Abstract][Full Text] [Related]
33. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
34. [Aromatase inhibitors: pharmacological aspects].
de Crémoux P
Bull Cancer; 2000 Dec; 87 Spec No():23-29. PubMed ID: 11250605
[TBL] [Abstract][Full Text] [Related]
35. ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancer.
Buzdar AU; Jonat W; Howell A; Plourde PV
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):145-9. PubMed ID: 9365184
[TBL] [Abstract][Full Text] [Related]
36. Toremifene and letrozole for advanced breast cancer.
Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744
[No Abstract] [Full Text] [Related]
37. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
38. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
Friedrichs K; Jänicke F
Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
[TBL] [Abstract][Full Text] [Related]
39. Aromatase inhibitors in breast cancer: an update.
Lake DE; Hudis C
Cancer Control; 2002; 9(6):490-8. PubMed ID: 12514567
[TBL] [Abstract][Full Text] [Related]
40. Anti-aromatase agents in the treatment and prevention of breast cancer.
Goss P
Cancer Control; 2002; 9(2 Suppl):2-8. PubMed ID: 11965225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
